Bergen Brunswig Reports Earnings Gain of 17% for First Quarter
ORANGE —
Bergen Brunswig Corp. posted a 17% gain in earnings on record sales for the first fiscal quarter.
The Orange distributor of pharmaceuticals and medical-surgical supplies said net earnings for the three months ended Dec. 31 rose to $18.2 million, or 45 cents a share, from $15.6 million, or 39 cents a share, for the same period last year. Revenue rose nearly 17%, to $2.8 billion, from $2.4 billion.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
